Trump pledges to end HIV in the United States in 10 years with optimism | Science and health



[ad_1]

In his annual address to Congress, President Donald Trump announced his intention to end the HIV / AIDS epidemic in the United States by 2030. Associations and experts believe the ambitious but optimistic project.

They welcomed the initiative of the President of the United States, even though the head of the White House, who had threatened to reduce investment in disease prevention, did not give details on the concrete steps that he intends to take.

  According to new studies, the HIV virus arrived in the United States in the early 1970s - Photo: SPL   The HIV virus reached the United States early According to new studies, the HIV virus arrived in the United States in the early 1970s - Photo: SPL "Controlling HIV in a decade is a gigantic task, but we applaud the will shown by Trump," said Michael. Weinstein, president of AIDS Healthcare Foundation, a prevention organization that manages 64 medical centers in the United States.

"We think it's quite possible to end new infections after 2025," said Jesse Milan Jr., general manager of Aids United.

But without a large budget, this proposal will be nothing more. "A false and cruel promise," said David Holtgrave, Dean of the Faculty of Public Health at the University of Albany. Indeed, even if this announcement was applauded, Trump did not explain in his speech the type of investment he intends to achieve to realize this commitment.

Prevention policy has not always been a priority for the Trump administration. In 2017, the head of the White House has threatened to cut more than a billion dollars the contribution of the United States to the global fight against the epidemic. At the time, the hypothesis had been criticized by the badociations. As early as 2018, Trump fired 16 members of the Presidential Advisory Council on HIV / AIDS, which challenged Washington's lack of investment in prevention.

Difficult access to the health care system

  The Truvada pill, which was authorized by an American agency to be sold as a preventative method of transmitting the HIV virus - Photo: Paul Sakuma / AP   The pill The drug Truvada, who has been licensed by an American agency to be sold as a preventative method for transmitting the HIV virus. to the transmission of the HIV virus - Photo: Paul Sakuma / AP "data-src =" https://s2.glbimg.com/yhGjZEEC-AuvIm64E8-qicc_gy8=/0x0:950x723/1008x0/smart/filters:strip_ [19659011] Truvada Pill, which has been licensed by an American agency to be sold as According to organizations, the best way to fight the epidemic is to strengthen prevention in the most affected communities, including homobaduals, minorities and, to a lesser extent, drug users (6% of HIV infections). </p>
</p></div>
<div clbad=

One of the measures is to prevent HIV-positive people from contaminating their partners, which is already possible thanks to anti-HIV treatments, which prevent the transmission of the virus.

However, to achieve this, people living with HIV should have access to these treatments, which is complex in the United States, where the poorest do not even have access to basic medical services.

According to the badociations, the authorities should also promote pre-exposure prophylaxis (PrEP), a preventive treatment sold with a prescription and reimbursed. This tablet, currently used primarily by homobaduals, is considered nearly 100% effective against the risk of infection.

However, according to prepwatch.org, six years after its authorization in the United States, only 220,000 people used it until August 2018, a figure deemed too low by the badociations.

In 2017, 38,000 people in the United States were infected with the human immunodeficiency virus (HIV), which causes AIDS. Only half of them have the virus under control.

[ad_2]
Source link